Cough, Cold and Allergy (Hay Fever) Remedies in Japan

In 2024, cough, cold, and allergy (hay fever) remedies in Japan is set to see only slow growth in retail current value terms. Despite the category benefiting from the proliferation of various infectious diseases in this year, including COVID-19, colds, and influenza, there has been a lower pollen count than in the previous year, which is expected to drive a decline for systemic antihistamines/allergy remedies, and hamper growth in the overall category.

The Cough, Cold and Allergy (Hay Fever) Remedies in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.